|
|
|
|
|
|
|
|
132nd MAINE LEGISLATURE |
|
|
LD 1847 |
|
LR 854(03) |
|
|
|
An Act to
Institute Testing and Tracking of Medical Use Cannabis and Cannabis Products
Similar to Adult Use Cannabis and Cannabis Products, Dedicate a Portion of
the Adult Use Cannabis Sales and Excise Tax to Medical Use Cannabis Programs
and Create a Study Group |
|
Fiscal Note for
Bill as Amended by Committee Amendment " " |
|
Committee: Veterans and Legal Affairs |
|
Fiscal Note Required: Yes |
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fiscal Note |
|
|
|
|
|
|
|
|
|
|
FY 2025-26 |
FY 2026-27 |
Projections FY 2027-28 |
Projections FY 2028-29 |
| Net Cost
(Savings) |
|
|
|
|
|
|
General Fund |
|
$0 |
$14,100 |
$18,500 |
$17,800 |
|
|
|
|
|
|
|
| Appropriations/Allocations |
|
|
|
|
|
|
Other Special Revenue Funds |
|
$0 |
$0 |
$5,279,988 |
$5,546,988 |
|
|
|
|
|
|
|
| Revenue |
|
|
|
|
|
|
General Fund |
|
$0 |
($14,100) |
($18,500) |
($17,800) |
|
Other Special Revenue Funds |
|
$0 |
$2,100 |
$3,500 |
$3,800 |
|
|
|
|
|
|
|
| Fiscal Detail
and Notes |
|
|
|
|
|
|
This bill
establishes mandatory testing and audit testing programs for the medical use
of cannabis, an electronic inventory tracking system and a data management
system and makes associated changes to record-keeping, labeling and
regulatory requirements for registrants and cannabis testing facilities,
including changes to the excise tax treatment of certain cannabis products.
This estimate is based on an implementation model in which audit testing
would be conducted on a recurring basis across a substantial portion of
registrants and would require centralized sample collection, analysis and
ongoing compliance monitoring activities supported by dedicated field,
supervisory and analytical staff. |
|
The Office of
Cannabis Policy (OCP) within the Department of Administrative and Financial
Services has indicated that implementation of the provisions of this bill
would require additional resources to support testing oversight, audit
testing activities, data management, and program administration. OCP would
require ongoing Other Special Revenue Funds allocations of $3,369,874
beginning in fiscal year 2027-28 for 15 OCP Compliance Inspector positions, 3
Field Investigator Supervisor positions, one Chemist II position, 5 Planning
and Research Associate II positions, 2 Public Service Coordinator I
positions, one Public Relations Representative position, and associated
position costs. The staffing levels reflect assumptions regarding the scope
and frequency of audit testing activities and assume that OCP would be
responsible for sample collection, coordination with testing facilities and
evaluation of results.
|
|
OCP would also
require ongoing Other Special Revenue Funds allocations for the development
and maintenance of data management capabilities to support audit testing,
trip ticket reporting and compliance monitoring activities, as well as
ongoing allocations of $1,143,114 for audit testing costs based on the
assumed frequency and scope of audit testing activities. |
|
In addition, OCP
would require Other Special Revenue Funds allocations of $267,000 beginning
in fiscal year 2027-28 for costs associated with the procurement and
implementation of an electronic inventory tracking system. |
|
The use of
additional Other Special Revenue Funds allocations from the Maine Medical Use
of Cannabis Fund to support the expenditures estimated in this bill would
increase the rate at which the fund balance is drawn down. Based on current
revenue levels and projected expenditures, the fund balance may be depleted
more quickly than it is replenished. This could require the identification of
alternative funding sources in future biennia and may affect the availability
of the fund to support other statutorily authorized purposes, including
ongoing program administration and regulatory activities. |
|
The bill would
result in a revenue decrease to the General Fund of $14,100 in fiscal year
2026-27, $18,500 in fiscal year 2027-28 and $17,800 in fiscal year 2028-29
from increased prices leading to a reduction in quantity sold in the medical
market with a partially offsetting increase in sales of adult use cannabis.
The bill would also result in a revenue increase to the Local Government Fund
and the Adult Use Cannabis Public Health and Safety Fund totaling $2,100 in
fiscal year 2026-27, $3,500 in fiscal year 2027-28 and $3,800 in fiscal year
2028-29. |
|
Implementation of
the program is expected to occur over time due to rulemaking and a 12- to
18-month procurement process for the inventory-tracking system. As a result,
costs in fiscal year 2026-27 are expected to be limited to initial
implementation activities. The costs described above represent the estimated
resources necessary to support full program implementation beginning in
fiscal year 2027-28. |
|
|
|
|
|
|
|